AI Article Synopsis
- A deeper understanding of HIV replication and effective drug combinations has led to long-term antiretroviral therapies, but these are not cures and must be maintained for life.
- Elite controllers (ECs), a small group of HIV-infected individuals who do not need therapy, may provide insights into achieving a functional cure.
- Research revealed that ECs had undetectable levels of serum IFNα and showed no immune dysfunction, contrasting with untreated non-EC patients who exhibited significant immune impairment, suggesting elevated IFNα plays a crucial role in driving HIV-related immune issues.
Article Abstract
Background: A complete understanding of the different steps of HIV replication and an effective drug combination have led to modern antiretroviral regimens that block HIV replication for decades, but these therapies are not curative and must be taken for life. "Elite controllers" (ECs) is a term for the 0.5% of HIV-infected persons requiring no antiretroviral therapy, whose status may point the way toward a functional HIV cure. Defining the mechanisms of this control may be key to understanding how to replicate this functional cure in others.
Methods: In ECs and untreated non-EC patients, we compared IFNα serum concentration, distribution of immune cell subsets, and frequency of cell markers associated with immune dysfunction. We also investigated the effect of an elevated dose of IFNα on distinct subsets within dendritic cells, natural killer cells, and CD4+ and CD8 + T cells.
Results: Serum IFNα was undetectable in ECs, but all immune cell subsets from untreated non-EC patients were structurally and functionally impaired. We also show that the altered phenotype and function of these cell subsets in non-EC patients can be recapitulated when cells are stimulated in vitro with high-dose IFNα.
Conclusions: Elevated IFNα is a key mediator of HIV pathogenesis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10951235 | PMC |
| http://dx.doi.org/10.1038/s43856-024-00454-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Microbiome of esophageal endoscopic wash samples is associated with resident flora in the esophagus and incidence of cancer.
Sci Rep
August 2024
Third Department of Internal Medicine, Kansai Medical University, 2-5-1 Shin-Machi, Hirakata, Osaka, 573-1010, Japan.
Change in mucosal microbiome is associated with various types of cancer in digestive tract. We hypothesized that microbial communities in the esophageal endoscopic wash fluids reflects resident flora in esophageal mucosa that is associated with esophageal carcinoma (EC) risk and/or directly correlates microbiome derived from EC tumor tissue. Studying microbial communities in esophageal endoscopic wash samples would be therefore useful to predict the incidence or risk of EC.
View Article and Find Full Text PDFThe endometrial cancer detection using non-invasive hypermethylation of and genes in women with postmenopausal bleeding in Northwest China.
Cytojournal
April 2024
Department of Obstetrics and Gynecology, Gansu Provincial Maternity and Child-care Hospital, Lanzhou, China.
Objective: The objective of this study was to verify the clinical predictive performance of methylated cysteine dioxygenase type 1 () and CUGBP Elav-like family member 4 () in endometrial cancer (EC) women with postmenopausal bleeding (PMB).
Material And Methods: A single-center, prospective, and case-control study was conducted in the Gansu Provincial Maternity and Child-care Hospital with 138 female postmenopausal patients enrolled in 2022. All patients underwent body mass index (BMI) detection, transvaginal ultrasonography (TVUS) detection, carbohydrate antigen 125 detection, and the cervical exfoliated cell gene methylation detection to analyze the sensitivity, specificity, and accuracy of different screening tests statistically with the biopsy and/or dilation and curettage (D&C) pathological diagnosis under hysteroscopy as the gold standard.
Background: An epicardial connection (EC) through the intercaval bundle (EC-ICB) between the right pulmonary vein (RPV) and right atrium (RA) is one of the reasons for the need for carina ablation for PV isolation and may reduce the acute and chronic success of PV isolation. We evaluated the intra-atrial activation sequence during RPV pacing after failure of ipsilateral RPV isolation and sought to identify specific conduction patterns in the presence of EC-ICB.
Methods And Results: This study included 223 consecutive patients who underwent initial catheter ablation of atrial fibrillation.
Conditional survival and annual hazard of death in older patients with esophageal cancer receiving definitive chemoradiotherapy.
BMC Geriatr
April 2024
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, 100142, Beijing, China.
Background: Definitive chemoradiotherapy is one of the primary treatment modalities for older patients with esophageal cancer (EC). However, the evolution of prognosis over time and the factors affected non-EC deaths remain inadequately studied. We examined the conditional survival and annual hazard of death in older patients with EC after chemoradiotherapy.
View Article and Find Full Text PDFEarly elevated IFNα is a key mediator of HIV pathogenesis.
Commun Med (Lond)
March 2024
21CBIO, Paris, France.
Article Synopsis
- A deeper understanding of HIV replication and effective drug combinations has led to long-term antiretroviral therapies, but these are not cures and must be maintained for life.
- Elite controllers (ECs), a small group of HIV-infected individuals who do not need therapy, may provide insights into achieving a functional cure.
- Research revealed that ECs had undetectable levels of serum IFNα and showed no immune dysfunction, contrasting with untreated non-EC patients who exhibited significant immune impairment, suggesting elevated IFNα plays a crucial role in driving HIV-related immune issues.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!